CDKN2A, which encodes the CDK inhibitor p16INK4a and p14ARF protein, is located upstream of the cell cycle progression pathway and could be found loss-of-function in multiple human tumors, including NSCLC (9). This evidence concerns the gene CDKN2A and non-small cell lung carcinoma.